(Alliance News) - Aptamer Group PLC on Wednesday announced increased interim revenue together with plans to raise funds which it said will boost growth and provide a cash runway through to 2028.
The York, England-based synthetic binders developer said its pretax loss was flat at GBP1.2 million in the six months to December from the year prior.
Revenue increased 27% to GBP828,000 from GBP653,000, with cost of sales rising 29% to GBP368,000 from GBP286,000.
Chief Executive Arron Tolley said the first half of the financial year saw Aptamer make "meaningful progress across all three pillars of its strategy: fee‑for‑service, asset development and licensing," with the Optimer platform now generating its first product‑linked revenue.
To help fund further growth, Aptamer announced plans to raise up to GBP3.8 million via a placing and subscription to new and existing institutional investors at 0.6 pence per share. It also intends to raise GBP500,000 via a retail offer at the same price.
Aptamer said funds will provide a cash runway through to 2028.
Aptamer will issue one warrant for every three shares issued in the fundraise. Each warrant will entitle the holder to subscribe for one new share at any time in the two years from the date of grant.
Shares in Aptamer were flat at 0.65p each in London on Wednesday.
Around GBP750,000 of proceeds will be used for working capital, with GBP1.1 million for development of the group's liver fibrosis delivery vehicle and targeted radio pharmaceutical pipeline. A further GBP1.1 million will be used to build and deploy an AI‑enabled Optimer discovery engine, with GBP400,000 allocated to enhance manufacturing capabilities.
CEO Tolley said: "This investment will allow us to develop new proprietary assets, creating further value for shareholders, while funding the development of our AI‑enhanced fee‑for‑service offering and the systematic exploration of undruggable and undeliverable targets using our novel oligonucleotide‑based platform."
Turner Pope Investments Ltd is acting as sole bookrunner and sole broker in respect of the placing.
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Corporate News Finance and Instruments Pharmaceuticals Health Care

CyanConnode Holdings PLC - Cambridge, England-based developer of narrowband radio frequency mesh networks - Put up or shut up deadline for possible bi...


Cambridge Cognition Holdings PLC - brain health software provider based in Cambridge, England - Plans to raise a minimum of GBP2.5 million through a G...


Pri0r1ty Intelligence Group PLC - London-based software-as-a-service company focused on AI - Says that all conditions relating to funding under the ar...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...


(Sharecast News) - Aptamer Group said on Monday that it had launched a funded research programme with Imperial College London to develop a rapid testi...


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.


(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...


(Alliance News) - Aptamer Group PLC on Wednesday announced increased interim revenue together with plans to raise funds which it said will boost growt...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: